Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: UNIVERSITY OF FLORIDA
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-28 to 2023-09-29
Current total value of award: $499445
Description: WE AIM TO CONDUCT A RANDOMIZED, CONTROLLED CLINICAL TRIAL IN CRITICALLY ILL PATIENTS WITH SEVERE PNEUMONIA RECEIVING BETA-LACTAM THERAPY AS CONTINUOUS VS. INTERMITTENT INFUSION FOR GRAM-NEGATIVE INFECTIONS AND ASSESS THE DEVELOPMENT OF NEW BACTERIA